Advertisement

Strategies in Lead Selection and Optimization: Application of a Graphical Model and Automated In Vitro ADME Screening

  • A. K. Mandagere
Part of the Ernst Schering Research Foundation Workshop book series (SCHERING FOUND, volume 37)

Abstract

The drug discovery process in the pharmaceutical industry has undergone a dramatic change in the last decade due to advances in molecular biology, high-throughput pharmacological screens and combinatorial synthesis. In addition, the high cost, the long development time and the high failure rate in bringing drugs to market have also been the driving forces behind this change. The convergence of computational power, information management, robotics and automation technologies have aided in the dramatic acceleration in the pace of early drug discovery.

Keywords

Oral Bioavailability Metabolic Stability Hepatic Extraction Ratio Absolute Oral Bioavailability Lead Selection 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Artursson P, Karlsson J (1991) Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells. Biochem Biophys Res Commun 175: 880–885PubMedCrossRefGoogle Scholar
  2. Artursson P, Katrin P, Luthman K (1996) Caco-2 monolayers in experimental and theoretical predictions of drug transport. Adv Drug Deliv Rev 22: 67–84CrossRefGoogle Scholar
  3. Berman J, Halm K, Adkison K, Shaffer J (1997) Simultaneous pharmacokinetic screening of a mixture of compounds in the dog using API LC/MS/MS analysis for increased throughput. J Med Chem 40: 827: 829Google Scholar
  4. Bevan CD, Lloyd RS (2000) A high-throughput screening method for the determination of aqueous drug solubility using laser nephelometry in microtiter plates. Anal Chem. 72: 1781–1787PubMedCrossRefGoogle Scholar
  5. Bryant MS, Korfmacher WA, Wang SY, Nardo C, Nomeir AA, Lin CC (1997) Pharmacokinetics screening for the selection of new drug discovery candidates is greatly enhanced through the use of liquid chromatography atmospheric pressure ionization tandem mass spectrometry. J Chromatogr 777: 61–66CrossRefGoogle Scholar
  6. Chiou WL, Barve A (1998) Linear Correlation of the fraction of oral dose ab- sorbed of 64 drugs between humans and rats. Pharm Res 15: 1792–1795PubMedCrossRefGoogle Scholar
  7. Delie F, Rubas W (1997) A human colonic cell line sharing similarities with enterocytes as a model to examine oral absorption: advantages and limitations of the Caco-2 model. Crit Rev Ther Drug Carrier Syst 14 (3): 221–286PubMedCrossRefGoogle Scholar
  8. Garberg P, Eriksson P, Schipper N, Sjostrom B (1999) Automated absorption assessment using Caco-2 cells cultured on both sides of polycarbonate membranes. Pharm Res 16: 441–445PubMedCrossRefGoogle Scholar
  9. Ho JC, Brown PW, Emary WB, Thompson TN, Toren PC, Yerino PP (1999) Higher throughput metabolic stability screen. Annual AAPS conference, New OrleansGoogle Scholar
  10. Irvine J, Takahashi L, Lockhart K, Cheong J, Tolan J, Selick H, Grove R (1999) MDCK (Madin-Darby Canine Kidney) cells: a tool for membrane permeability screening. J Pharm Sci 88:28 —33Google Scholar
  11. Iwatsubo T, Hirota N, Ooie T, Suzuki H, Shimada N, Chiba K, Ishizaki T, Green C, Tyson C, Sugiyama Y (1997) Prediction of in vivo drug metabolism in the human liver from in vitro metabolism data Pharmacol Ther 73: 147–171Google Scholar
  12. Kennedy T (1997). Managing the drug discovery/development interface. Drug Discov Today 2: 436–444CrossRefGoogle Scholar
  13. Lave T, Dupin S, Schmitt Valles B, Ubeaud G, Chou RC, Jaeck D, Coassolo P (1997) The use of human hepatocytes to select compounds based on their expected hepatic extraction ratios in humans Pharm Res 14: 152–155Google Scholar
  14. Lipinski CA, Lombardo F, Dominy BW, Feeney PJ (1997) Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 23: 3–25CrossRefGoogle Scholar
  15. Mandagere AK (2000) Automation of higher throughput in vitro ADME screening system for lead candidate selection in drug discovery and development. Millennial World Congress of the Pharmaceutical Sciences, San Francisco, CAGoogle Scholar
  16. Mandagere A, Thompson T, Hwang K (2002), A graphical method for estimating oral bioavailability of drugs in humans and other species from their Caco-2 permeability and in vitro liver enzyme metabolic stability rates. J Med Chem 45: 304–311PubMedCrossRefGoogle Scholar
  17. Mandagere AK, Correll MA, Mooney JP, Poole JC, Hwang KK, Cheng LK (1996) Application of automation to Caco-2 drug diffusion studies. Pharm Res 13: S237Google Scholar
  18. Mandagere AK, Yerino PP, Miller T, Connor LA, Danison T, Geary JL, Thompson TN (1999) Validation of automated in vitro drug inhibition studies using the Hamilton Microlab 2200 mph work station: inhibition of Terfenadine oxidation by troleandomycin and fluconazole as a case study. Pharm ResGoogle Scholar
  19. Obach R.S, Baxter J.G, Liston T.E, Silber M R, Jones B.C. MacIntyre F, Rance DJ, Wastall P (1997) The prediction of human pharmacokinetic parameters from preclinical and in vitro metabolism data. J Pharmacol Exp Ther 283: 46–58PubMedGoogle Scholar
  20. Olah TV, McLoughlin DA, Gilbert JD (1997) The simultaneous determination of mixtures of drug candidates by liquid chromatography/atmospheric pressure chemical ionization mass spectrometry as an in vivo drug screening procedure. Rapid Commun Mass Spectrom 11: 17–23PubMedCrossRefGoogle Scholar
  21. Prentis RA, Lis Y, Walker SR (1988) Pharmaceutical innovation by the seven UK-owned pharmaceutical companies (1964–1985). Brit J Clin Pharmacol 25: 387–396CrossRefGoogle Scholar
  22. Rubas W, Villagran J, Cromwell M, McLeod A, Wassenberg J, Mrsny R (1995) Correlation of solute flux across Caco-2 monolayers and colonic tissue in vitro. STP Pharm Sci 5 (1): 93–97Google Scholar
  23. Sietsema WK (1989) The absolute oral bioavailability of selected drugs. Int J Clin Pharmacol Ther Toxico127: 179–211Google Scholar
  24. Smith AD (1994) Design of drugs through a consideration of drug metabolism and pharmacokinetics. Eur J Drug Metab Pharmacokinet 3: 193–199CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2002

Authors and Affiliations

  • A. K. Mandagere

There are no affiliations available

Personalised recommendations